Two-week course of sleep aid increases CPAP adherence in OSA patients at six months

New research suggests that patients newly diagnosed with obstructive sleep apnea (OSA) who use a short-course of the sleep aid, eszopiclone, when beginning continuous positive airway pressure (CPAP) therapy, are more adherent with therapy in six months.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news161871789.html">Two-week course of sleep aid increases CPAP adherence in OSA patients at six months</a></p> <p>New research suggests that patients newly diagnosed with obstructive sleep apnea (OSA) who use a short-course of the sleep aid, eszopiclone, when beginning continuous positive airway pressure (CPAP) therapy, are more adherent with therapy in six months.</p>